Tuberculosis (Edinb)
December 2022
Tuberculosis (Edinb)
January 2022
Multidrug-resistant tuberculosis (isoniazid/rifampin[RIF]-resistant TB) ravages developing countries. Fitness is critical in clinical outcomes. Previous studies on RIF-resistant TB (RR-TB) showed competitive fitness gains and losses, with rpoB-S450L as the most isolated/fit mutation.
View Article and Find Full Text PDF